Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases.
Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases.
复制标题
DOI:
10.3389/fphys.2023.1263420
复制
发表时间:
2023
影响因子:
4
通讯作者:
中科院分区:
文献类型:
--
作者:
Most mitochondrial proteins are targeted to the organelle by N-terminal mitochondrial targeting sequences (MTSs, or “presequences”) that are recognized by the import machinery and subsequently cleaved to yield the mature protein. MTSs do not have conserved amino acid compositions, but share common physicochemical properties, including the ability to form amphipathic α-helical structures enriched with basic and hydrophobic residues on alternating faces. The lack of strict sequence conservation implies that some polypeptides can be mistargeted to mitochondria, especially under cellular stress. The pathogenic accumulation of proteins within mitochondria is implicated in many aging-related neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s diseases. Mechanistically, these diseases may originate in part from mitochondrial interactions with amyloid-β precursor protein (APP) or its cleavage product amyloid-β (Aβ), α-synuclein (α-syn), and mutant forms of huntingtin (mHtt), respectively, that are mediated in part through their associations with the mitochondrial protein import machinery. Emerging evidence suggests that these amyloidogenic proteins may present cryptic targeting signals that act as MTS mimetics and can be recognized by mitochondrial import receptors and transported into different mitochondrial compartments. Accumulation of these mistargeted proteins could overwhelm the import machinery and its associated quality control mechanisms, thereby contributing to neurological disease progression. Alternatively, the uptake of amyloidogenic proteins into mitochondria may be part of a protein quality control mechanism for clearance of cytotoxic proteins. Here we review the pathomechanisms of these diseases as they relate to mitochondrial protein import and effects on mitochondrial function, what features of APP/Aβ, α-syn and mHtt make them suitable substrates for the import machinery, and how this information can be leveraged for the development of therapeutic interventions.
登录
查看更多内容
DOI:
10.3233/jad-2011-101716
发表时间:
2011
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
Alikhani N;Guo L;Yan S;Du H;Pinho CM;Chen JX;Glaser E;Yan SS
通讯作者:
Yan SS
影响因子:
4
作者:
Genge MG;Mokranjac D
通讯作者:
Mokranjac D
影响因子:
4.1
作者:
Ahmad Z;Laughlin TF
通讯作者:
Laughlin TF
影响因子:
4
作者:
Amorim IS;Graham LC;Carter RN;Morton NM;Hammachi F;Kunath T;Pennetta G;Carpanini SM;Manson JC;Lamont DJ;Wishart TM;Gillingwater TH
通讯作者:
Gillingwater TH
影响因子:
6
作者:
通讯作者:
--